We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$4.21M
(-0.39%)
Cap. Flow
-$36.2M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.36M |
| 2 |
Aon
AON
|
+$3.22M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.48M |
| 4 |
Microsoft
MSFT
|
+$1.54M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oaktree Specialty Lending
OCSL
|
+$12.7M |
| 2 |
NVIDIA
NVDA
|
+$6.29M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.66M |
| 4 |
Apple
AAPL
|
+$3.19M |
| 5 |
Broadcom
AVGO
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.21% |
| 2 | Financials | 12.25% |
| 3 | Healthcare | 6.29% |
| 4 | Communication Services | 4.39% |
| 5 | Consumer Discretionary | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Sarepta Therapeutics
SRPT
$1.74B
| $19.6K | ﹤0.01% |
124
-15
| -11% | -$1.93K |
|
1252
NMI Holdings
NMIH
$3.34B
| $19.6K | ﹤0.01% |
575
-25
| -4% | -$804 |
|
1253
Coherent
COHR
$67.8B
| $19.6K | ﹤0.01% |
270
+207
| +329% | +$12.4K |
|
|
CADE
1254
DELISTED
Cadence Bank
CADE
| $19.4K | ﹤0.01% |
687
| – | – |
|
1255
First Merchants
FRME
$2.68B
| $19.4K | ﹤0.01% |
582
+106
| +22% | +$3.54K |
|
|
SQSP
1256
DELISTED
Squarespace, Inc.
SQSP
| $19.4K | ﹤0.01% |
444
+138
| +45% | +$5.52K |
|
1257
Advanced Energy
AEIS
$13.1B
| $19.4K | ﹤0.01% |
178
+10
| +6% | +$1.02K |
|
1258
Fabrinet
FN
$19.6B
| $19.3K | ﹤0.01% |
79
+36
| +84% | +$7.64K |
|
1259
Vanguard S&P 500 Value ETF
VOOV
$6.74B
| $19.3K | ﹤0.01% |
110
| – | – |
|
1260
Sabra Healthcare REIT
SBRA
$5.27B
| $19.3K | ﹤0.01% |
1,255
-12
| -0.9% | -$171 |
|
1261
MKS Inc
MKSI
$20.2B
| $19.3K | ﹤0.01% |
148
+95
| +179% | +$12K |
|
|
MZTI
1262
The Marzetti Company
MZTI
$3.13B
| $19.3K | ﹤0.01% |
102
-3
| -3% | -$573 |
|
1263
Oscar Health
OSCR
$8.8B
| $19.3K | ﹤0.01% |
1,217
+91
| +8% | +$1.67K |
|
|
OGI
1264
Organigram Holdings
OGI
$139M
| $19.3K | ﹤0.01% |
12,501
| – | – |
|
1265
TPG
TPG
$7.86B
| $19.2K | ﹤0.01% |
464
+330
| +246% | +$14.1K |
|
1266
Portland General Electric
POR
$5.67B
| $19.2K | ﹤0.01% |
444
+257
| +137% | +$11.1K |
|
1267
First Horizon
FHN
$12B
| $19.2K | ﹤0.01% |
1,215
+400
| +49% | +$6.06K |
|
1268
PTC Therapeutics
PTCT
$6.15B
| $19.1K | ﹤0.01% |
626
+105
| +20% | +$3.4K |
|
1269
Zillow
ZG
$7.47B
| $19.1K | ﹤0.01% |
425
+159
| +60% | +$6.86K |
|
1270
Global Net Lease
GNL
$1.93B
| $19.1K | ﹤0.01% |
2,594
+1,609
| +163% | +$11.7K |
|
1271
Prospect Capital
PSEC
$1.14B
| $19K | ﹤0.01% |
3,440
| – | – |
|
1272
Universal Health Services
UHS
$10.4B
| $18.9K | ﹤0.01% |
102
+23
| +29% | +$4.07K |
|
1273
Stanley Black & Decker
SWK
$15.4B
| $18.9K | ﹤0.01% |
236
+3
| +1% | +$264 |
|
1274
Telefônica Brasil
VIV
$19B
| $18.8K | ﹤0.01% |
2,295
-525
| -19% | -$4.75K |
|
|
GLDD
1275
DELISTED
Great Lakes Dredge & Dock
GLDD
| $18.8K | ﹤0.01% |
2,145
+176
| +9% | +$1.5K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.
- Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
- Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
- Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
- Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
- Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
- Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
- Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.
Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.